Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 347
Filter
1.
Int J Immunogenet ; 48(2): 193-200, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33112034

ABSTRACT

The implementation of the immune checkpoint blockade as a therapeutic option in contemporary oncology is one of the significant immunological achievements in the last century. Constantly accumulating evidence suggests that the response to immune checkpoint inhibitors (ICIs) is not universal. Therefore, it is critical to identify determinants for response, resistance and adverse effects of immune checkpoint therapy that could be developed as prognostic and predictive markers. Recent large scale analyses of cancer genome data revealed the key role of HLA class I and class II molecules in cancer immunoediting, and it appears that HLA diversity can predict response to ICIs. In the present review, we summarize the emerging data on the role of HLA germline variations as a marker for response to ICIs.


Subject(s)
Antigens, Neoplasm/immunology , Drug Resistance, Neoplasm/immunology , HLA Antigens/physiology , Immune Checkpoint Inhibitors/pharmacology , Immunotherapy , Neoplasms/immunology , Antigen Presentation , Antigens, Neoplasm/genetics , Antineoplastic Agents, Immunological/immunology , Antineoplastic Agents, Immunological/therapeutic use , B7-H1 Antigen/immunology , Drug Resistance, Neoplasm/genetics , Genes, MHC Class I , Genes, MHC Class II , Genetic Variation , Genotype , Germ-Line Mutation , HLA Antigens/genetics , Humans , Immune Checkpoint Inhibitors/therapeutic use , Neoplasms/drug therapy , Neoplasms/genetics , Prognosis , Programmed Cell Death 1 Receptor/immunology , Self Tolerance/genetics , Self Tolerance/immunology , T-Lymphocytes, Cytotoxic/immunology , Tumor Escape
2.
Neuromolecular Med ; 22(4): 464-473, 2020 12.
Article in English | MEDLINE | ID: mdl-32894413

ABSTRACT

Alzheimer's disease (AD) is commonly considered as the most prominent dementing disorder globally and is characterized by the deposition of misfolded amyloid-ß (Aß) peptide and the aggregation of neurofibrillary tangles. Immunological disturbances and neuroinflammation, which result from abnormal immunological reactivations, are believed to be the primary stimulating factors triggering AD-like neuropathy. It has been suggested by multiple previous studies that a bunch of AD key influencing factors might be attributed to genes encoding human leukocyte antigen (HLA), whose variety is an essential part of human adaptive immunity. A wide range of activities involved in immune responses may be determined by HLA genes, including inflammation mediated by the immune response, T-cell transendothelial migration, infection, brain development and plasticity in AD pathogenesis, and so on. The goal of this article is to review the recent epidemiological findings of HLA (mainly HLA class I and II) associated with AD and investigate to what extent the genetic variations of HLA were clinically significant as pathogenic factors for AD. Depending on the degree of contribution of HLA in AD pathogenesis, targeted research towards HLA may propel AD therapeutic strategies into a new era of development.


Subject(s)
Alzheimer Disease/genetics , HLA Antigens/analysis , Alzheimer Disease/epidemiology , Alzheimer Disease/immunology , Alzheimer Disease/therapy , Animals , Antigens, Differentiation, B-Lymphocyte/physiology , Genetic Predisposition to Disease , Genetic Variation , Genome-Wide Association Study , HLA Antigens/genetics , HLA Antigens/immunology , HLA Antigens/physiology , Histocompatibility Antigens Class II/physiology , Humans , Immunity , Inflammation , Microglia/immunology , Nerve Tissue Proteins/physiology , Stem Cell Transplantation , T-Lymphocytes/immunology , T-Lymphocytes/physiology , Transendothelial and Transepithelial Migration
3.
Proc Biol Sci ; 287(1933): 20201682, 2020 08 26.
Article in English | MEDLINE | ID: mdl-32811307

ABSTRACT

Several studies have demonstrated that women show pre-copulatory mating preferences for human leucocyte antigen (HLA)-dissimilar men. A fascinating, yet unexplored, possibility is that the ultimate mating bias towards HLA-dissimilar partners could occur after copulation, at the gamete level. Here, we explored this possibility by investigating whether the selection towards HLA-dissimilar partners occurs in the cervical mucus. After combining sperm and cervical mucus from multiple males and females (full factorial design), we found that sperm performance (swimming velocity, hyperactivation, and viability) was strongly influenced by the male-female combination. This indicates that sperm fertilization capability may be dependent on the compatibility between cervical mucus (female) and sperm (male). We also found that sperm viability was associated with partners' HLA dissimilarity, indicating that cervical mucus may selectively facilitate later gamete fusion between immunogenetically compatible partners. Together, these results provide novel insights into the female-mediated sperm selection (cryptic female choice) in humans and indicate that processes occurring after copulation may contribute to the mating bias towards HLA-dissimilar partners. Finally, by showing that sperm performance in cervical mucus is influenced by partners' genetic compatibility, the present findings may promote a deeper understanding of infertility.


Subject(s)
Cervix Mucus/physiology , HLA Antigens/physiology , Spermatozoa/physiology , Humans , Infertility , Male , Reproduction
4.
Hum Cell ; 33(3): 537-544, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32449112

ABSTRACT

Previous studies have shown that some specific long non-coding RNAs are dysregulated in vascular walls and abnormally expressed in vascular disease. LncRNA HLA complex group 18 (HCG18) is a member of the HLA complex group, which has been rarely investigated in human diseases. In this study, we aimed to investigate the role of HCG in vascular smooth muscle cells. HCG18 was over-expressed by adenovirus transfection and knocked down in vascular smooth muscle cells by shRNA. Cell proliferation was detected by CCK-8 assays. Flow cytometry was employed to test the impacts of HCG18 on vascular smooth muscle apoptotic cells. The expression of associated genes in protein and mRNA levels was detected by western blotting, immunofluorescence and qRT-PCR. The interactions between HCG18 and fused in sarcoma (FUS) were confirmed by RNA EMSA and RIP assays. The expression of serum HCG18 was decreased in hypertensive patients and PDGF-BB-treated vascular smooth muscle cells. HCG18 inhibited proliferation and induced apoptotic cells in vascular smooth muscle cells. In addition, we also found that HCG18 can inhibit vascular smooth muscle cell phenotypic switching from a contractile to a secretory phenotype. Finally, our results showed that HCG18 enhanced apoptotic cells by directly binding with FUS. Our findings reveal that HCG18 is involved in the regulation of proliferation, apoptosis and the expression levels of markers of the contractile and synthetic phenotype.


Subject(s)
Cell Proliferation/genetics , HLA Antigens/physiology , Muscle, Smooth, Vascular/cytology , Phenotype , RNA, Long Noncoding/physiology , Apoptosis/genetics , Cells, Cultured , Gene Expression/genetics , HLA Antigens/genetics , Humans , RNA, Long Noncoding/genetics , RNA, Long Noncoding/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism
5.
Autoimmun Rev ; 18(9): 102349, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31323359

ABSTRACT

Myasthenia gravis (MG) is a rare autoimmune disease characterized by muscle weakness and abnormal fatigability. Like many other autoimmune diseases, genetic contribution to MG has been studied where the HLA system appears to play the most vital role. Although many correlations have been revealed in these studies, the underlying mechanism for them is still in the veil. Based on current evidence, we propose two synergetic mechanisms underlying the MG predisposition via HLA. In brief, the first advocates specific MHC II-peptide patterns that influence the efficacy of antigen presentation, and the second emphasizes the role of classical MHC alleles in shaping the TCR repertoire for MG predisposition. Besides, possible explanations for unresolved or controversial MG-related epidemiological phenomenon or clinical problems are addressed as well. Then, we discuss three factors influencing the effect of HLA on MG: gender discrepancy, inflammatory microenvironment, and epigenetic regulation. Lastly, from a provisional angle, we introduce several precautious treatments for people highly predisposed to MG. Although this is a review focusing on MG, the underlying mechanisms might be applicable in other autoimmune diseases as well.


Subject(s)
HLA Antigens/physiology , Myasthenia Gravis/genetics , Alleles , Cellular Microenvironment/genetics , Cellular Microenvironment/immunology , Epigenesis, Genetic/physiology , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , HLA Antigens/genetics , Humans , Myasthenia Gravis/epidemiology , Myasthenia Gravis/immunology , Myasthenia Gravis/therapy , Sex Factors , Signal Transduction
6.
Ann Clin Transl Neurol ; 6(5): 962-967, 2019 May.
Article in English | MEDLINE | ID: mdl-31139694

ABSTRACT

Associations between human leukocyte antigen (HLA) and postural orthostatic tachycardia syndrome (POTS) have not been investigated. We included patients diagnosed with POTS and showing orthostatic heart rate increases ≥ 50 during orthostatic vital sign measurement or experiencing syncope/near-syncope while standing (prominent POTS; n = 17). DQB1*06:09 was present in seven (41%) patients, a significantly higher percentage than in healthy Koreans (7%; odds ratio [OR] 8.7, 95% confidence interval [CI] 3.1-24.3, corrected P = 3.2 × 10-4) and epilepsy controls (8%; OR 7.9, 95% CI 2.7-23.5, corrected P = 3.2 × 10-4). Six (35.3%) carried the A*33:03-B*58:01-C*03:02-DRB1*13:02-DQB1*06:09 haplotype. The results signify an autoimmune etiology in prominent POTS.


Subject(s)
HLA Antigens/physiology , Postural Orthostatic Tachycardia Syndrome/genetics , Postural Orthostatic Tachycardia Syndrome/physiopathology , Adolescent , Adult , Blood Pressure , Female , Heart Rate , Humans , Male , Receptor, Angiotensin, Type 1/genetics , Receptors, Adrenergic/genetics , Syncope
7.
Nat Rev Rheumatol ; 15(6): 364-381, 2019 06.
Article in English | MEDLINE | ID: mdl-31092910

ABSTRACT

Our understanding of the mechanisms underlying HLA associations with inflammatory arthritis continues to evolve. Disease associations have been refined, and interactions of HLA genotype with other genes and environmental risk factors in determining disease risk have been identified. This Review provides basic information on the genetics and molecular function of HLA molecules, as well as general features of HLA associations with disease. Evidence is discussed regarding the various peptide-dependent and peptide-independent mechanisms by which HLA alleles might contribute to the pathogenesis of three types of inflammatory arthritis: rheumatoid arthritis, spondyloarthritis and systemic juvenile idiopathic arthritis. Also discussed are HLA allelic associations that shed light on the genetic heterogeneity of inflammatory arthritides and on the relationships between adult and paediatric forms of arthritis. Clinical implications range from improved diagnosis and outcome prediction to the possibility of using HLA associations in developing personalized strategies for the treatment and prevention of these diseases.


Subject(s)
Arthritis/etiology , HLA Antigens/genetics , Arthritis/genetics , HLA Antigens/physiology , Humans , Inflammation/etiology , Inflammation/genetics
8.
Med Sci Monit ; 25: 952-961, 2019 Feb 03.
Article in English | MEDLINE | ID: mdl-30712055

ABSTRACT

BACKGROUND Physical crossmatch (PXM) and virtual crossmatch (VXM) are applied to identify preexisting donor-specific human leukocyte antigen (HLA) antibodies in patients awaiting kidney transplantation. Recently, high-resolution epitope analysis has emerged as a novel strategy for VXM. A retrospective clinical study compared PXM with VXM before kidney transplantation and recipient outcome following transplantation. MATERIAL AND METHODS Between August 2017 and March 2018, 239 patients underwent crossmatching and 94 patients received a donor kidney. A complement-dependent cytotoxicity (CDC) PXM assay and VXM using serological and epitope analysis identified donor-specific antibodies (DSA). Crossmatch results and clinical outcome at 3 months were compared. RESULTS VXM identified serological DSA (sDSA), verified epitope DSA, and total epitope DSA in 74 (31.0%), 39 (16.3%), and 49 (20.5%) cases, respectively. Eleven cases (4.6%) had a positive PXM detected by the CDC assay. Of 94 kidney transplant recipients, 21 had preexisting sDSA but were negative in PXM; there was 1 case of delayed graft function (DGF) and no cases of hyperacute rejection or acute rejection. Of the rest of the 73 recipients who were negative for sDSA, 8 had acute rejection (P=0.253) and 19 had DGF (P=0.037). No significant differences were found in graft survival at 3 months. CONCLUSIONS High-resolution epitope analysis identified fewer cases with DSA compared with serological analysis. Because patients with and without sDSA had a similar short-term outcome in the setting of a negative PXM, the presence of preexisting sDSA, determined by VXM, should not be an absolute contraindication for kidney transplantation.


Subject(s)
Blood Grouping and Crossmatching/methods , HLA Antigens/classification , Adult , Antibodies/immunology , Female , Graft Rejection/immunology , Graft Survival/immunology , HLA Antigens/blood , HLA Antigens/physiology , Histocompatibility Antigens Class I/immunology , Humans , Kidney Transplantation/methods , Male , Middle Aged , Retrospective Studies , Tissue Donors
9.
Brain ; 141(8): 2263-2271, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29788256

ABSTRACT

The recent biochemical distinction between antibodies against leucine-rich, glioma-inactivated-1 (LGI1), contactin-associated protein-2 (CASPR2) and intracellular epitopes of voltage-gated potassium-channels (VGKCs) demands aetiological explanations. Given established associations between human leucocyte antigen (HLA) alleles and adverse drug reactions, and our clinical observation of frequent adverse drugs reactions in patients with LGI1 antibodies, we compared HLA alleles between healthy controls (n = 5553) and 111 Caucasian patients with VGKC-complex autoantibodies. In patients with LGI1 antibodies (n = 68), HLA-DRB1*07:01 was strongly represented [odds ratio = 27.6 (95% confidence interval 12.9-72.2), P = 4.1 × 10-26]. In contrast, patients with CASPR2 antibodies (n = 31) showed over-representation of HLA-DRB1*11:01 [odds ratio = 9.4 (95% confidence interval 4.6-19.3), P = 5.7 × 10-6]. Other allelic associations for patients with LGI1 antibodies reflected linkage, and significant haplotypic associations included HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02, by comparison to DRB1*11:01-DQA1*05:01-DQB1*03:01 in CASPR2-antibody patients. Conditional analysis in LGI1-antibody patients resolved further independent class I and II associations. By comparison, patients with both LGI1 and CASPR2 antibodies (n = 3) carried yet another complement of HLA variants, and patients with intracellular VGKC antibodies (n = 9) lacked significant HLA associations. Within LGI1- or CASPR2-antibody patients, HLA associations did not correlate with clinical features. In silico predictions identified unique CASPR2- and LGI1-derived peptides potentially presented by the respective over-represented HLA molecules. These highly significant HLA associations dichotomize the underlying immunology in patients with LGI1 or CASPR2 antibodies, and inform T cell specificities and cellular interactions at disease initiation.10.1093/brain/awy109_video1awy109media15796480660001.


Subject(s)
HLA Antigens/metabolism , HLA Antigens/physiology , Membrane Proteins/physiology , Nerve Tissue Proteins/physiology , Proteins/physiology , Adult , Aged , Aged, 80 and over , Alleles , Autoantibodies/metabolism , Epitopes , Female , Gene Frequency/genetics , Genetic Linkage/genetics , HLA-DRB1 Chains/genetics , HLA-DRB1 Chains/physiology , Haplotypes , Humans , Intracellular Signaling Peptides and Proteins , Male , Membrane Proteins/genetics , Middle Aged , Nerve Tissue Proteins/genetics , Potassium Channels, Voltage-Gated/genetics , Potassium Channels, Voltage-Gated/immunology , Potassium Channels, Voltage-Gated/physiology , Proteins/genetics , White People/genetics
10.
Clin J Gastroenterol ; 11(1): 11-18, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29159718

ABSTRACT

Primary biliary cholangitis (PBC) is a chronic, slowly progressive cholestatic autoimmune liver disease predominantly afflicting women. PBC is characterized by the presence of disease-specific antimitochondrial antibodies and the histological destruction of intrahepatic bile ducts, which eventually lead to cirrhosis and hepatic failure. Fortunately, ursodeoxycholic acid therapy has improved the outcome of the vast majority of PBC cases. Although the etiology of PBC has not yet been elucidated, human leukocyte antigen (HLA) class II alleles have been consistently associated with disease onset for decades. PBC patients may also have genetically determined risk factors in non-HLA regions. Meanwhile, exposure to environmental factors, such as infectious diseases and harmful chemicals, can produce epigenetic alterations in some individuals and subsequent PBC onset. In this review, we describe the influence of HLA alleles and other gene polymorphisms on PBC along with the results of genome-wide association studies on this disease and its future prospects in terms of epigenetics.


Subject(s)
Cholangitis/genetics , Epigenesis, Genetic , Genome-Wide Association Study , HLA Antigens/physiology , Alleles , Environmental Exposure , Genetic Predisposition to Disease , Humans , Interleukin-12/physiology , Microsatellite Repeats , Polymorphism, Single Nucleotide , Signal Transduction
11.
Transplant Proc ; 47(8): 2425-32, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26518945

ABSTRACT

The risk of rejection by cellular alloreactivity to the transplant donor is not routinely assessed. Here we analyzed alloreactive T cells in kidney transplant recipients and report how their detection may have helped to prevent rejection of a second kidney graft in a patient with a history of acute accelerated steroid-resistant nonhumoral rejection. Alloreactive CD4 and CD8 T cells were quantified using a flow-cytometric mixed lymphocyte reaction assay based on interferon-γ induction. A group of 16 nonrejecting transplant recipients did not show any alloreactive T-cell immunity to their respective donors, whereas alloreactivity to third-party controls was detectable. In the patient with rejection, HLA-specific antibodies were not detectable before and shortly after rejection, but after transplantation the patient showed exceptionally high frequencies of alloreactive T cells against 2 of 11 HLA-typed controls (0.604% and 0.791% alloreactive CD4 T cells and 0.792% and 0.978% alloreactive CD8 T cells) who shared HLA alleles (HLA-A*24, -B*44, -C*02, -DQB1*5) with the kidney donor. These HLA alleles were subsequently excluded for allocation of a second graft. No alloreactive T cells were observed toward the second kidney donor, and this transplantation was performed successfully. Thus, shared HLA alleles between the donor and third-party controls may suggest that alloreactive T cells had contributed to rejection of the first graft. The rejecting patient highlights that determination of cellular alloreactivity before transplantation may be applied to identify unacceptable mismatches and to reduce the risk for acute cellular rejection episodes.


Subject(s)
Graft Rejection/immunology , HLA Antigens/physiology , Kidney Failure, Chronic/surgery , Kidney Transplantation , T-Lymphocytes/physiology , Adult , Case-Control Studies , Female , Flow Cytometry , Histocompatibility Testing , Humans , Kidney Failure, Chronic/immunology , Lymphocyte Culture Test, Mixed , Male , Middle Aged , Reoperation , Risk
12.
G Ital Nefrol ; 32 Suppl 642015.
Article in Italian | MEDLINE | ID: mdl-26479049

ABSTRACT

There are many evidences that the HLA genes are risk factors for kidney complex disease for the pathogenesis of which an abnormal response of the immune system is involved. In this review, we present the latest knowledge about the genetics of the HLA complex, the molecules encoded by the HLA genes, their polymorphism and the physiological role of the HLA system in the defense against infections. It then addresses the issue of the association between specific alleles of HLA and renal disorders. Many kidney diseases have been described associated with HLA. This review focuses on some examples of renal diseases, exploring in detail how certain HLA antigens are a risk factor for idiopathic membranous glomerulonephritis, Goodpasture's disease and vasculitis associated with the presence of ANCA. These diseases indeed offer a good example of how the presence of some variants of HLA class II genes in individuals who possess them promote the presentation of peptides derived from certain self proteins, able to initiate the autoimmune response. Immunogenetic study of many complex renal diseases can be useful for the understanding of their pathogenesis and the possible development of new therapies.


Subject(s)
Glomerulonephritis/genetics , Glomerulonephritis/immunology , Immunogenetic Phenomena , Anti-Glomerular Basement Membrane Disease/genetics , Anti-Glomerular Basement Membrane Disease/immunology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/genetics , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology , HLA Antigens/physiology , Humans
13.
Rev Bras Reumatol ; 54(1): 38-43, 2014.
Article in English, Portuguese | MEDLINE | ID: mdl-24878790

ABSTRACT

PURPOSE: The aim of the present study was to investigate the HLA phenotype in Dupuytren's contracture (DC) patients in order to verify the correlation of these alleles with risk factors for development of DC in the Brazilian population. METHODS: This was a case-controlled study of 25 DC patients and 443 healthy individuals with no history of HLA-associated diseases. HLA class I and class II typing was performed using the polymerase chain reaction sequence-specific primer method. RESULTS: The HLAB*18 phenotype was observed in 32% of the patients and 10.5% of controls. However, P values did not remain significant after correction. DISCUSSION: Although we observed an increased tendency of DC patients to possess the HLA-B*18 allele, the results were not statistically significant after correction. This allele was higher in patients of Italian and/or Spanish ethnicity, localities with frequencies higher than 18.0% and 14.0% respectively. Further investigation with a larger cohort of DC patients is required to confirm the potential role of HLA in this disease.


Subject(s)
Dupuytren Contracture/immunology , HLA Antigens/physiology , Adult , Aged , Brazil , Case-Control Studies , Female , Humans , Male , Middle Aged
14.
Rev. bras. reumatol ; 54(1): 38-43, Jan-Feb/2014. tab
Article in Portuguese | LILACS, Sec. Est. Saúde SP, SESSP-ILSLPROD, Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: lil-704290

ABSTRACT

Objetivo: O objetivo deste estudo foi investigar o fenótipo do HLA em pacientes com contratura de Dupuytren (CD) para verificar a correlação desses alelos com os fatores de risco para o desenvolvimento da CD na população brasileira. Métodos: Este foi um estudo de caso-controle de 25 pacientes com CD e 443 indivíduos saudáveis sem histórico de doenças associadas ao HLA. As tipagens classe I e classe II do HLA foram feitas utilizando o método iniciador de sequências específicas da reação em cadeia da polimerase. Resultados: O fenótipo HLA-B*18 foi observado em 32% dos pacientes e 10,5% do grupo controle. Contudo, os valores de p não permaneceram significativos após correção. Discussão: Apesar de termos observado um aumento na tendência de os pacientes com CD terem o alelo HLA-B*18, os resultados não foram estatisticamente significativos após correção. Esse alelo foi maior em pacientes de etnia italiana e/ou espanhola, locais com frequências superiores a 18% e 14%, respectivamente. São necessárias investigações adicionais com uma coorte maior de pacientes com CD para confirmar o possível papel do HLA nessa doença. .


Purpose: The aim of the present study was to investigate the HLA phenotype in Dupuytren's contracture (DC) patients in order to verify the correlation of these alleles with risk factors for development of DC in the Brazilian population. Methods: This was a case-controlled study of 25 DC patients and 443 healthy individuals with no history of HLA-associated diseases. HLA class I and class II typing was performed using the polymerase chain reaction sequence-specific primer method. Results: The HLAB*18 phenotype was observed in 32% of the patients and 10.5% of controls. However, P values did not remain significant after correction. Discussion: Although we observed an increased tendency of DC patients to possess the HLA-B*18 allele, the results were not statistically significant after correction. This allele was higher in patients of Italian and/or Spanish ethnicity, localities with frequencies higher than 18.0% and 14.0% respectively. Further investigation with a larger cohort of DC patients is required to confirm the potential role of HLA in this disease. .


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Dupuytren Contracture/immunology , HLA Antigens/physiology , Brazil , Case-Control Studies
15.
Clin Transplant ; 27 Suppl 26: 2-8, 2013.
Article in English | MEDLINE | ID: mdl-24299229

ABSTRACT

Chronic antibody-mediated rejection (C-AMR) is the most important and leading cause of graft loss after kidney transplantation. Although it is well known that chronic renal allograft dysfunction or failure is caused by various immunological or non-immunological factors, donor-specific anti-human leukocyte antigen antibodies (DSAs) are considered to be the most detrimental to graft survival and could cause C-AMR. Despite the use of intensive treatment for C-AMR, outcomes have not always been promising. Recently, prevention, rather than treatment, of C-AMR has been attempted, and this approach appears to be a more effective option for reducing the incidence of C-AMR and, ultimately, improving long-term survival. To prevent C-AMR, removal of antibodies, inactivation of antibodies, and prevention of antibody production after kidney transplantation are essential. Preconditioning treatment including plasmapheresis, intravenous immunoglobulin, and rituximab injection seems the most effective of current desensitization protocols. In this minireview, we will focus on the prevention of C-AMR through desensitization and improving long-term graft survival.


Subject(s)
Desensitization, Immunologic , Graft Rejection/immunology , Graft Rejection/prevention & control , Kidney Transplantation , Transplantation Conditioning , Chronic Disease , HLA Antigens/physiology , Humans , Isoantibodies/physiology
16.
Semin Ophthalmol ; 28(5-6): 333-6, 2013.
Article in English | MEDLINE | ID: mdl-24138042

ABSTRACT

Chronic uveitides can lead to serious sequlae over time including blindness. Human Leukocyte antigen (HLA) plays an important role in immunological response of the eyes. Some of these uveitides are associated with certain Human Leukocyte antigen (HLA) types. This article reviews these relationships and their significance.


Subject(s)
HLA Antigens/physiology , Uveitis/immunology , Vision Disorders/immunology , Animals , Chronic Disease , Humans
17.
Hepatology ; 58(3): 881-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23532923

ABSTRACT

UNLABELLED: CD8+ T-cell responses to hepatitis C virus (HCV) are important in generating a successful immune response and spontaneously clearing infection. Human leukocyte antigen (HLA) class I presents viral peptides to CD8+ T cells to permit detection of infected cells, and tapasin is an important component of the peptide loading complex for HLA class I. We sought to determine if tapasin polymorphisms affected the outcome of HCV infection. Patients with resolved or chronic HCV infection were genotyped for the known G/C coding polymorphism in exon 4 of the tapasin gene. In a European, but not a US, Caucasian population, the tapasin G allele was significantly associated with the outcome of HCV infection, being found in 82.5% of resolvers versus 71.3% of persistently infected individuals (P = 0.02, odds ratio [OR] = 1.90 95% confidence interval [CI] = 1.11-3.23). This was more marked at the HLA-B locus at which heterozygosity of both tapasin and HLA-B was protective (P < 0.03). Individuals with an HLA-B allele with an aspartate at residue 114 and the tapasin G allele were more likely to spontaneously resolve HCV infection (P < 0.00003, OR = 3.2 95% CI = 1.6-6.6). Additionally, individuals with chronic HCV and the combination of an HLA-B allele with an aspartate at residue 114 and the tapasin G allele also had stronger CD8+ T-cell responses (P = 0.02, OR = 2.58, 95% CI-1.05-6.5). CONCLUSION: Tapasin alleles contribute to the outcome of HCV infection by synergizing with polymorphisms at HLA-B in a population-specific manner. This polymorphism may be relevant for peptide vaccination strategies against HCV infection.


Subject(s)
HLA Antigens/physiology , Hepacivirus , Hepatitis C/drug therapy , Hepatitis C/physiopathology , Membrane Transport Proteins/physiology , Adult , Alleles , Antiviral Agents/therapeutic use , Cohort Studies , Female , HLA Antigens/genetics , HLA-B Antigens/genetics , HLA-B Antigens/physiology , Humans , Logistic Models , Male , Membrane Transport Proteins/genetics , Middle Aged , Polymorphism, Genetic/genetics , Prognosis , Treatment Outcome
18.
Mol Immunol ; 55(1): 2-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23046976

ABSTRACT

The human major histocompatibility complex is a multi-gene ~4 Mb of DNA including the highly polymorphic HLA genes which are fundamental in effecting a healthy immune response. Detailed knowledge of the structure and function of HLA genes and their alleles and HLA proteins and their allotypes has rapidly evolved because of their role in clinical transplantation. A significant additional finding is the association or linkage of a wide range of diseases with HLA. We review the function of HLA and the history of disease association studies and focus on specific informative examples in the context of recent genome-wide screening analyses.


Subject(s)
Disease , HLA Antigens/physiology , Health , Disease/etiology , Disease/genetics , Genetic Association Studies/statistics & numerical data , Genetic Predisposition to Disease , HLA Antigens/genetics , HLA Antigens/immunology , HLA Antigens/metabolism , Humans , Immunity/genetics , Major Histocompatibility Complex/genetics , Major Histocompatibility Complex/physiology , Models, Biological , Polymorphism, Genetic/physiology
19.
Fortschr Neurol Psychiatr ; 80(11): 627-34, 2012 Nov.
Article in German | MEDLINE | ID: mdl-22696207

ABSTRACT

Narcolepsy is a rare and chronic sleep disorder, characterised by excessive daytime sleepiness. Frequently associated signs are cataplexy, sleep paralysis and hypnagogic or hypnopompic hallucinations. Advances in understanding the pathogenesis of the disease have essentially been elucidated during the last fifteen years. The most significant finding has been the discovery of hypocretin-1 and -2 in 1998. Hypocretin-containing cells have widespread projections throughout the entire CNS and play a crucial role in the regulation of the sleep-wake cycle. They also contribute to olefaction and to the regulation of food intake. Animal models and human studies concordantly show that the disturbed hypocretin system is the probable cause of narcolepsy. However, it remains unclear why there is neuronal death of hypocretin-producing cells in the lateral hypothalamus. As the HLA-allele DQB1*0602 is associated with narcolepsy and hypocretin deficiency, an autoimmune reaction against hypocretin-producing neurons has been vigorously discussed. Newly discovered gene polymorphisms as well as previously unknown pathogenetic mechanisms, linking the sleep-wake cycle with the immune system, may also contribute to the pathogenetic cascade. Worthy of mention in this context is, e.g., the "insulin-like growth factor"-binding protein 3 (IGFBP3), whose overexpression causes a down-regulation of the hypocretin production. Substitution of the deficient neuropeptides by hypocretin agonists may become the causal treatment strategy of the future, if an adequate administration route can be found. Presently, animal trials, including genetic therapy, cell transplantations or the administration of hypocretin receptor agonists, are underway.


Subject(s)
HLA Antigens/physiology , Intracellular Signaling Peptides and Proteins/deficiency , Narcolepsy/epidemiology , Narcolepsy/physiopathology , Neuropeptides/deficiency , Animals , Disease Models, Animal , HLA Antigens/genetics , Humans , Hypothalamus, Middle/metabolism , Hypothalamus, Middle/physiology , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/cerebrospinal fluid , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/physiology , Narcolepsy/diagnosis , Narcolepsy/drug therapy , Narcolepsy/genetics , Neuropeptides/antagonists & inhibitors , Neuropeptides/cerebrospinal fluid , Neuropeptides/genetics , Neuropeptides/physiology , Neurotransmitter Agents/physiology , Orexins
20.
Cold Spring Harb Perspect Med ; 2(1): a007732, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22315720

ABSTRACT

Genetic susceptibility to type 1 diabetes (T1D) has been a subject of intensive study for nearly four decades. This article will present the history of these studies, beginning with observations of the Human Leukocyte Antigen (HLA) association in the 1970s, through the advent of DNA-based genotyping methodologies, through recent large, international collaborations and genome-wide association studies. More than 40 genetic loci have been associated with T1D in multiple studies; however, the HLA region, with its multiple genes and extreme polymorphism at those loci, remains by far the greatest contributor to the genetic susceptibility to T1D. Even after decades of study, the complete story has yet to unfold, and exact mechanisms by which HLA and other associated loci confer T1D susceptibility remain elusive.


Subject(s)
Diabetes Mellitus, Type 1/genetics , Genetic Predisposition to Disease/genetics , HLA Antigens/genetics , Genome-Wide Association Study , Genotyping Techniques , HLA Antigens/chemistry , HLA Antigens/physiology , Haplotypes , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...